Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.58 USD | +0.18% | +2.65% | +14.28% |
11-27 | Gilead Sciences, Inc. Announces New England Journal of Medicine Publication of PURPOSE 2 Results | CI |
11-22 | UBS Raises Price Target on Gilead Sciences to $96 From $70, Maintains Neutral Rating | MT |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Argus Cuts Price Target on Gilead Sciences to $75 From $85